Presentation is loading. Please wait.

Presentation is loading. Please wait.

Eligibility criteria for inclusion as an expert Delphi panellist

Published byJuha Härkönen Modified over 5 years ago

Similar presentations

Presentation on theme: "Eligibility criteria for inclusion as an expert Delphi panellist"— Presentation transcript:

1 Eligibility criteria for inclusion as an expert Delphi panellist
Eligibility criteria for inclusion as an expert Delphi panellist. CD, Crohns disease; IBD, inflammatory bowel disease; NHS, National Health Service; UC, ulcerative colitis. Eligibility criteria for inclusion as an expert Delphi panellist. CD, Crohns disease; IBD, inflammatory bowel disease; NHS, National Health Service; UC, ulcerative colitis. Pritesh S Morar et al. Frontline Gastroenterol doi: /flgastro Copyright © BMJ Publishing Group Ltd & British Society of Gastroenterology. All rights reserved.

Download ppt "Eligibility criteria for inclusion as an expert Delphi panellist"

Similar presentations

Inflammatory Bowel Disease: Overview

Inflammatory Bowel Disease: Overview
Work disability in inflammatory bowel disease

Work disability in inflammatory bowel disease
Medical management of inflammatory bowel disease

Medical management of inflammatory bowel disease
distinguishing IBD versus D-IBS.

distinguishing IBD versus D-IBS.
Comparison of DNA rates between standard lists and BCSP lists across UK. BCSP, Bowel Cancer Screening Programme; DNA, did not attend; NHS, National Health.

Comparison of DNA rates between standard lists and BCSP lists across UK. BCSP, Bowel Cancer Screening Programme; DNA, did not attend; NHS, National Health.
Example of algorithm for clinical assessment of patients at risk of non-alcoholic fatty liver disease.36 37 44 . Example of algorithm for clinical assessment.

Example of algorithm for clinical assessment of patients at risk of non-alcoholic fatty liver disease Example of algorithm for clinical assessment.
Sedentary time was higher in non-alcoholic fatty liver disease (NAFLD) than healthy controls with fewer sedentary to active transitions (data reported.

Sedentary time was higher in non-alcoholic fatty liver disease (NAFLD) than healthy controls with fewer sedentary to active transitions (data reported.
Example of algorithm for clinical assessment of patients at risk of non-alcoholic fatty liver disease.36 37 44 . Example of algorithm for clinical assessment.

Example of algorithm for clinical assessment of patients at risk of non-alcoholic fatty liver disease Example of algorithm for clinical assessment.
A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.

A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.
Scores of 64 irritable bowel syndrome (IBS) patients (top figure).

Scores of 64 irritable bowel syndrome (IBS) patients (top figure).
Audit data for new outpatient attendances in August 2014 following GP referral at Taunton and Somerset NHS Foundation Trust (TST) and Yeovil District NHS.

Audit data for new outpatient attendances in August 2014 following GP referral at Taunton and Somerset NHS Foundation Trust (TST) and Yeovil District NHS.
The pathway for commencement of thiopurines and monitoring.

The pathway for commencement of thiopurines and monitoring.
Individual patients’ FCP (μg/g) values (n=119).

Individual patients’ FCP (μg/g) values (n=119).
Masashi Maeda et al. Heart Asia 2013;5:7-14

Masashi Maeda et al. Heart Asia 2013;5:7-14
Preprocedure patient ranking of aspects of their care important for obtaining satisfaction with their colonoscopy experience (1=high, 15=low for importance)

Preprocedure patient ranking of aspects of their care important for obtaining satisfaction with their colonoscopy experience (1=high, 15=low for importance)
Modelled changes in gastrointestinal endoscopy activity 2013/2014 to 2019/2020.43 2WW, 2-week wait; BCSP, Bowel Cancer Screening Programme; FIT, faecal.

Modelled changes in gastrointestinal endoscopy activity 2013/2014 to 2019/ WW, 2-week wait; BCSP, Bowel Cancer Screening Programme; FIT, faecal.
(A) Sedation reversal and type of procedure.

(A) Sedation reversal and type of procedure.
Integration of prognostic screening tool and development of supportive care intervention using rapid-cycle ‘Plan-Do-Study-Act’ (PDSA) methodology. Integration.

Integration of prognostic screening tool and development of supportive care intervention using rapid-cycle ‘Plan-Do-Study-Act’ (PDSA) methodology. Integration.
Distinguishing organic disease versus D-IBS.

Distinguishing organic disease versus D-IBS.
Respondent suggestions as to how best to protocol case selection for the inflammatory bowel disease (IBD) multidisciplinary team (MDT)—application of an.

Respondent suggestions as to how best to protocol case selection for the inflammatory bowel disease (IBD) multidisciplinary team (MDT)—application of an.

Similar presentations

Ads by Google